
|Articles|October 1, 2012
'Zero ischemia' robotic partial nephrectomy comes with benefits, risks
It's hard to argue with the statement that no ischemia is probably better than some ischemia, but at what cost?
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
4
The UroOnc Minute: Variant Histologies in Bladder Cancer, With Carissa Chu, MD
5











